National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
   
 
Results: 1 -6 of 6         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II, Phase I


Treatment


Completed


18 and over


Other


2003-1027
NCT00113334


2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Completed


18 and over


Pharmaceutical / Industry


M02-534
NCT00061659


3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Completed


18 and over


Pharmaceutical / Industry


M02-457
NCT00061672

Last Modified: 10/8/2004     First Published: 2/20/2004  

4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Closed


18 and over


NCI, Pharmaceutical / Industry


UCLA-0308112
ABBOTT-M02-428, NCT00080704

Last Modified: 1/11/2008     First Published: 1/10/2008  

5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Biomarker/Laboratory analysis, Treatment


Closed


18 and over


NCI


MAYO-MC0375
MC0375, NCT00602199

Last Modified: 8/21/2007     First Published: 1/6/2006  

6.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Treatment


Closed


18 and over


NCI


DUMC-6074-05-7R1ER
DUMC-6074, NCT00276562

   
   

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov